Mercer Global Advisors
NVAX icon

Mercer Global Advisors’s Novavax NVAX Stock Holding History

Mercer Global Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Buy
+40,327
New +$361K ﹤0.01% 2562
2025
Q3 		– Sell
-13,742
Closed -$86.6K – 2711
2025
Q2 		$86.6K Buy
+13,742
New +$91K ﹤0.01% 2169
2022
Q2 		– Sell
-2,948
Closed -$217K – 1889
2022
Q1 		$217K Buy
2,948
+632
+27% +$56.4K ﹤0.01% 1687
2021
Q4 		$331K Sell
2,316
-424
-15% -$72.9K ﹤0.01% 1410
2021
Q3 		$568K Buy
2,740
+761
+38% +$168K ﹤0.01% 1110
2021
Q2 		$420K Buy
+1,979
New +$363K ﹤0.01% 1228

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Mercer Global Advisors's NVAX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Novavax (NVAX) in Q2 2026: 40,327 shares worth $380K. The stake represents ﹤0.01% of the portfolio and ranks #2562 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in NVAX as recently as Q2 2025.

Mercer Global Advisors first reported a position in NVAX in Q2 2021 and has held it in 6 quarters since. The position peaked at $568K in Q3 2021. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Mercer Global Advisors held 40,327 shares of Novavax worth $380K as of Q2 2026.
  • Novavax was a new Mercer Global Advisors position in Q2 2026.
  • Novavax made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2562 holding.
  • Mercer Global Advisors first reported a position in Novavax in Q2 2021 and has held it in 6 quarters since.
  • Mercer Global Advisors's Novavax position peaked at $568K in Q3 2021.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.